Literature DB >> 4726068

Action of chloroquine phosphate in rheumatoid arthritis. 1. Immunosuppressive effect.

G S Panayi, W A Neill, J J Duthie, J N McCormick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4726068      PMCID: PMC1006108          DOI: 10.1136/ard.32.4.316

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  SUPPRESSION OF IN VITRO LYMPHOCYTE RESPONSES BY CHLOROQUINE.

Authors:  D HURVITZ; K HIRSCHHORN
Journal:  N Engl J Med       Date:  1965-07-01       Impact factor: 91.245

2.  Medical and social aspects of the treatment of rheumatoid arthritis; with special reference to factors affecting prognosis.

Authors:  J J DUTHIE; M THOMPSON; M M WEIR; W B FLETCHER
Journal:  Ann Rheum Dis       Date:  1955-06       Impact factor: 19.103

3.  Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year.

Authors:  A FREEDMAN; V L STEINBERG
Journal:  Ann Rheum Dis       Date:  1960-09       Impact factor: 19.103

4.  Chloroquine diphosphate in rheumatoid arthritis. A controlled trial.

Authors:  A J POPERT; K A MEIJERS; J SHARP; F BIER
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

Review 5.  Chloroquine: mechanism of action.

Authors:  W M Sams
Journal:  Mayo Clin Proc       Date:  1967-05       Impact factor: 7.616

6.  Lymphocytes in congenital immunological deficiency diseases.

Authors:  S P Gotoff
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

7.  Leukocytes cultured from small inocula of whole blood and the preparation of metaphase chromosomes by treatment with hypotonic KCl.

Authors:  D A Hungerford
Journal:  Stain Technol       Date:  1965-11

8.  Effect of chloroquine on morphology of cytoplasmic granules in maturing human leukocytes--an ultrastructural study.

Authors:  M Fedorko
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

  8 in total
  9 in total

1.  Studies on synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  P J Sheldon; M Papamichail; E J Holborow
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

2.  Cytology of rheumatoid synovial cells in culture. II. Association of polykarocytes with rheumatoid and other forms of arthritis.

Authors:  G S Panayi; J M Mackay; W A Neill; J N McCormick; B P Marmion; J J Duthie
Journal:  Ann Rheum Dis       Date:  1974-05       Impact factor: 19.103

3.  Action of chloroquine phosphate in rheumatoid arthritis. II. Chromosome damaging effect.

Authors:  W A Neill; G S Panayi; J J Duthie; R J Prescott
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

Review 4.  Systemic lupus erythematosus--disease management.

Authors:  M F Gourley
Journal:  Springer Semin Immunopathol       Date:  1994

5.  The presence of abnormal lysosomes in lymphocytes and neutrophils during chloroquine therapy: a quantitative ultrastructural study.

Authors:  C J Jones; R S Salisbury; M I Jayson
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

6.  Effects of fenoprofen and benoxaprofen on human lymphocytes: inhibition of tritiated thymidine uptake.

Authors:  R S Panush
Journal:  Agents Actions       Date:  1978-04

7.  Effects of therapeutic drugs on lymphocyte transformation.

Authors:  W R Williams; L A Davidson
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

Review 8.  Overcoming Chemoresistance: Altering pH of Cellular Compartments by Chloroquine and Hydroxychloroquine.

Authors:  Peter W Halcrow; Jonathan D Geiger; Xuesong Chen
Journal:  Front Cell Dev Biol       Date:  2021-02-09

Review 9.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.